Table 6

Analysis of MSI and MLH1 or MGMT methylation
Methylated and MSI PTC FTC Benign
N (%) N (%) N (%)
MLH1 24/31 (77%)* 3/4 (75%) 4/9 (44%)
MGMT 38/45 (84%)** 7/8 (87%) 3/8 (37%)

*pā€‰=ā€‰0.079 compared with the benign group; **pā€‰=ā€‰0.01.

Santos et al.

Santos et al. BMC Cancer 2013 13:79   doi:10.1186/1471-2407-13-79

Open Data